Evidence map›Paper›PMID 38920896›Full record

ArticleInfectious disease reports2024

Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies in Healthcare Personnel in El Salvador Prior to Vaccination Campaigns.

José Elías Aguilar Ramírez, Adrianna Maliga, Allison Stewart, Allison Lino, José Eduardo Oliva, Xochitl Sandoval, Emily Zielinski-Gutierrez, Rafael Chacon-Fuentes, Parminder S Suchdev, Susana Zelaya and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Infectious disease reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

José Elías Aguilar RamírezEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0000-0002-1705-3278
Adrianna MaligaDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0002-8640-3761
Allison StewartCenters for Disease Control and Prevention, Central America Office, Guatemala City 01015, Guatemala.
Allison LinoDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0001-9903-8110
José Eduardo OlivaEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0000-0002-6005-0558
Xochitl SandovalEl Salvador National Institute of Health, San Salvador 1101, El Salvador.
Emily Zielinski-GutierrezCenters for Disease Control and Prevention, Central America Office, Guatemala City 01015, Guatemala.
Rafael Chacon-FuentesCenters for Disease Control and Prevention, Central America Office, Guatemala City 01015, Guatemala.
Parminder S SuchdevCenters for Disease Control and Prevention, Central America Office, Guatemala City 01015, Guatemala.ORCID 0000-0002-0350-3469
Susana ZelayaEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0000-0001-6500-1483
Mario SánchezEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0000-0001-5918-4906
Delmy Lisseth RecinosEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0009-0009-4882-1477
Beatriz LópezCenters for Disease Control and Prevention, Central America Office, Guatemala City 01015, Guatemala.
Ella HawesDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0003-0122-2193
Julie LiuDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.
Shannon E RoncaDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.
Sarah M GunterDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.
Kristy O MurrayDivision of Pediatric Tropical Medicine, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX 77030, USA.ORCID 0000-0002-6921-3413
Rhina DomínguezEl Salvador National Institute of Health, San Salvador 1101, El Salvador.ORCID 0000-0001-7860-0602

Funding

ACL HHS U01GH002235CDC HHS U01 GH002235CGH CDC HHS U01 GH002235
6 · The paper itself

Abstract

COVID-19, caused by the SARS-CoV-2 virus, is a highly pathogenic emerging infectious disease. Healthcare personnel (HCP) are presumably at higher risk of acquiring emerging infections because of occupational exposure. The prevalence of COVID-19 in HCP is unknown, particularly in low- to middle-income countries like El Salvador. The goal of this study was to determine the seroprevalence of anti-SARS-CoV-2 antibodies among HCP in El Salvador just prior to vaccine rollout in March 2021. We evaluated 2176 participants from a nationally representative sample of national healthcare institutions. We found 40.4% (

Indexed as

COVID-19El SalvadorSARS-CoV-2seroprevalencespike protein

Identifiers

PMID38920896
PMCPMC11203478

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.